Drugs Made In America Acquisition (DMAA) Cash & Equivalents (2024 - 2025)
Drugs Made In America Acquisition's (DMAA) quarterly Cash & Equivalents came in at $6137.0 in Q4 2025, up 354.26% YoY from $1351.0 in Q4 2024, and up 755.93% on a QoQ basis from $717.0 in Q3 2025.
Drugs Made In America Acquisition (DMAA) Cash & Equivalents (2024 - 2025) Analysis & Trends
Drugs Made In America Acquisition (DMAA) has 2 years of Cash & Equivalents data on file, last reported at $6137.0 in Q4 2025.
- Quarterly Cash & Equivalents rose 354.26% year-over-year to $6137.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $6137.0 (up 354.26% YoY) and the FY2025 annual result came in at $6137.0, up 354.26% from the prior year.
- Cash & Equivalents climbed to $6137.0 in Q4 2025, from $717.0 in the prior quarter.
- In the past five years, Cash & Equivalents ranged from a high of $6137.0 in Q4 2025 to a low of $717.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Oxley Bridge Acquisition | 585.76 Mn | 585.76 Mn | - | 816,134.00 |
| 2 | Launch Two Acquisition | 557.86 Mn | 557.86 Mn | - | 250,000.00 |
| 3 | Drugs Made In America Acquisition | 507.00 Mn | 507.00 Mn | - | 174,974.00 |
| 4 | Cantor Equity Partners IV | 468.00 Mn | 468.00 Mn | - | 25,000.00 |
| 5 | GP-Act III Acquisition | 401.06 Mn | 401.06 Mn | - | 10,586.00 |
| 6 | Aldel Financial | 397.49 Mn | 397.49 Mn | - | 283,112.00 |
| 7 | Republic Digital Acquisition | 389.25 Mn | 388.51 Mn | - | 735,027.00 |
| 8 | Gores Holdings X | 385.06 Mn | 384.87 Mn | - | 194,541.00 |
| 9 | Agriculture & Natural Solutions Acquisition | 377.29 Mn | 377.04 Mn | - | 250,000.00 |
| 10 | Drugs Made In America Acquisition | 215.82 Mn | 215.82 Mn | - | 20,280.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 6,137.00 |
| Sep 30, 2025 | 717.00 |
| Jun 30, 2025 | 822.00 |
| Mar 31, 2025 | 923.00 |
| Dec 31, 2024 | 1,351.00 |